Related Experiment Video
Updated: May 30, 2026
08:08
Two-photon Imaging of Intracellular Ca2+ Handling and Nitric Oxide Production in Endothelial and Smooth Muscle Cells of an Isolated Rat Aorta
Published on: June 10, 2015
Susceptibility genes in hypertension.
C Armani1, N Botto, M G Andreassi
1Cardiovascular Research Laboratory, Cardiac Thoracic Vascular Department -University of Pisa, Pisa, Italy. armani.chiara@yahoo.it
Current Pharmaceutical Design
|August 25, 2011
Summary
Genetic factors significantly influence blood pressure, contributing to hypertension. Research is identifying novel genes for essential hypertension, aiming for future patient benefits through pharmacogenetics.
Area of Science:
- Genetics
- Molecular Biology
- Nephrology
Background:
- Hypertension is a complex disease with significant genetic influence, accounting for 33-50% of blood pressure variability.
- Monogenic forms of hypertension reveal a common mechanism of increased sodium reabsorption in the distal nephron.
- Essential hypertension involves complex interactions between multiple genes and environmental factors.
Purpose of the Study:
- To review current findings on candidate genes associated with blood pressure.
- To highlight recent advances in the pharmacogenetics of hypertension.
- To assess the potential clinical benefits of basic science research in hypertension genetics.
Main Methods:
- Review of molecular biology findings in Mendelian hypertension.
- Analysis of genome-wide association studies (GWAS) for essential hypertension.
- Functional analysis of novel candidate genes in experimental models.
Main Results:
- Discovery of novel and robust candidate genes for human essential hypertension.
- Identification of shared pathogenetic mechanisms, particularly sodium reabsorption.
- Advancements in understanding the genetic architecture of blood pressure regulation.
Conclusions:
- Genetic research, including GWAS and monogenic studies, is crucial for understanding hypertension.
- Pharmacogenetics holds promise for personalized hypertension treatment.
- Translating basic science discoveries into clinical benefits for patients is a key future goal.
Related Concept Videos
01:29Hypertension II: Pathophysiology
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
01:28Hypertension I: Introduction
Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
01:18Hypertension and Regulation of Blood Pressure
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:28Human Genetics
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
01:30Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...